Delivery Order SPE2DR25D1202-SPE2DR26F72BT
- Not listed
- The Defense Logistics Agency awarded a $1,202.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ultane 250 ml pen bottles. This firm fixed price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for Ultane Liquid 250ML with a ceiling value of $3,202.32. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on May 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- The Defense Logistics Agency awarded a delivery order valued at $3,176.58 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitive delivery order valued at $1,155.12 by the Defense Logistics Agency (DLA) for Ultane 250 ml in pen bottle format. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, and was competitively awarded without a set-aside designation. This award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a $1,443.90 delivery order to AmerisourceBergen Drug Corp for 250 ml of Ultane in a pen bottle configuration, with an ultimate completion date of October 17, 2025. This is a firm fixed price, competitively awarded order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,443.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ultane Liquid 250mL on September 16, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The work will be performed at the contractor's corporate office...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72BTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ultane 250 ML in pen bottle format, with a ceiling value of $1,118.40. This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, utilizing no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The company holds significant standing within the federal procurement landscape through its competitive awards and proven capability to deliver diverse pharmaceutical products across multiple therapeutic domains. This particular delivery order for Ultane, an inhalation anesthetic, supports the Defense Logistics Agency's medical supply chain requirements and aligns with the company's established role as a prime pharmaceutical vendor for Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/10/25 |